Skip to content

A Comparative Study of Serum HDL, Serum Creatinine and Serum C-reactive protein in assessing severity of sepsis.

Comparison of Serum HDL, Serum Creatinine, Serum C-reactive protein as predictors of severity in sepsis. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/02/062309
Enrollment
40
Registered
2024-02-06
Start date
Unknown
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: A00-B99- Certain infectious and parasitic diseases

Interventions

Sponsors

Calcutta National Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with age greater than 18 years and satisfying the criteria for sepsis according to International guidelines for management of severe sepsis and septic shock.

Exclusion criteria

Exclusion criteria: 1. Patients on treatment with statins. 2. Patients with chronic kidney disease, chronic liver disease, thyroid dysfunction, diabetes mellitus, and malabsorption disorders. 3. Patients with known chronic infective and inflammatory conditions like Human immunodeficiency virus disease, SLE(Systemic lupus erythematous) and RA( Rheumatoid arthritis)

Design outcomes

Primary

MeasureTime frame
The SOFA Score of patients who survives will be low and those who do not survive the score will be high. The three parameters may show the following outcomes: (i)The serum HDL-cholesterol values may be low in non survivors and may be high or within normal limits among the survivors. (ii)The serum CRP values are likely to be high among the non survivors and low among the non survivors. (iii)The serum creatinine levels are likely to be high in patients who will be progressing towards septic shock and MODS and finally death.Timepoint: Twelve months

Secondary

MeasureTime frame
All the three parameters in this study i.e. serum HDL, serum Creatinine, serum C- reactive protein will help in determining the disease progression in the patient so that prompt action can be taken in appropriate time to alter the course of disease with treatment modifications if possible, depending upon the patient’s clinical condition.Timepoint: Twelve months.

Countries

India

Contacts

Public ContactShivangi Singh

Calcutta National Medical College and Hospital

sudeshna04cmc@yahoo.co.in8777725424

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026